GB201715114D0 - 9 (11)-estosterene-16a, 17a-epoxy-3ß-ol-20-one drug intermediates synthesis method - Google Patents
9 (11)-estosterene-16a, 17a-epoxy-3ß-ol-20-one drug intermediates synthesis methodInfo
- Publication number
- GB201715114D0 GB201715114D0 GBGB1715114.3A GB201715114A GB201715114D0 GB 201715114 D0 GB201715114 D0 GB 201715114D0 GB 201715114 A GB201715114 A GB 201715114A GB 201715114 D0 GB201715114 D0 GB 201715114D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- estosterene
- epoxy
- synthesis method
- drug intermediates
- intermediates synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710870176.6A CN107589788B (en) | 2017-09-22 | 2017-09-22 | Separated VR display control method and device |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201715114D0 true GB201715114D0 (en) | 2017-11-01 |
Family
ID=60159426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1715114.3A Ceased GB201715114D0 (en) | 2017-09-22 | 2017-09-19 | 9 (11)-estosterene-16a, 17a-epoxy-3ß-ol-20-one drug intermediates synthesis method |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN107589788B (en) |
GB (1) | GB201715114D0 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114935969A (en) * | 2022-07-21 | 2022-08-23 | 杭州灵伴科技有限公司 | Head-mounted display suite and power-off method based on physical connection |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8855719B2 (en) * | 2009-05-08 | 2014-10-07 | Kopin Corporation | Wireless hands-free computing headset with detachable accessories controllable by motion, body gesture and/or vocal commands |
CN203136073U (en) * | 2013-01-04 | 2013-08-14 | 青岛海信电器股份有限公司 | Glasses and display device |
CN203759644U (en) * | 2013-12-31 | 2014-08-06 | 潍坊歌尔电子有限公司 | Device capable of reducing power consumption of wearable electronic equipment and wearable electronic equipment |
US9952652B2 (en) * | 2014-12-04 | 2018-04-24 | Htc Corporation | Virtual reality system and method for controlling operation modes of virtual reality system |
KR20170067058A (en) * | 2015-12-07 | 2017-06-15 | 엘지전자 주식회사 | Mobile terminal and method for controlling the same |
CN107357410B (en) * | 2017-07-14 | 2020-03-03 | 闻泰通讯股份有限公司 | Power consumption control method of split VR equipment and split VR equipment |
-
2017
- 2017-09-19 GB GBGB1715114.3A patent/GB201715114D0/en not_active Ceased
- 2017-09-22 CN CN201710870176.6A patent/CN107589788B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN107589788A (en) | 2018-01-16 |
CN107589788B (en) | 2020-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201715114D0 (en) | 9 (11)-estosterene-16a, 17a-epoxy-3ß-ol-20-one drug intermediates synthesis method | |
GB201705497D0 (en) | Medicine intermediates o-aminobiphenyl synthesis method | |
GB201719122D0 (en) | 5-pregneno-16ß-methyl-16a,17ß-epoxy-3ß-alcohol-20-ketone drug intermediates synthesis method | |
GB201715118D0 (en) | 5-pregnen-16a, 17a-epoxy-3ß-alcohol-20-one drug intermediates synthesis method | |
GB201719123D0 (en) | 2,3-dihydroxy-succinic acid drug intermediates synthesis method | |
GB201714450D0 (en) | 4,6-dihydroxyquinoline-5,8-diquinone-2-formic acid drug intermediates synthesis method | |
GB201714447D0 (en) | Drug intermediates 3,5-dimethoxybenzaldehyde synthesis method | |
GB201713388D0 (en) | Hormone drug intermediates 9(11)-pregnene-16ß-methyl-17a, 21-glycol-3, 20-diketone-21-acetate synthesis method | |
GB201715095D0 (en) | 1,2-naphthoquinone drug intermediates synthesis method | |
GB201708120D0 (en) | Drugs intermediates 3,4-dimethoxy-6-nitrobenzoic acid synthesis method | |
GB201714446D0 (en) | Drug intermediates 3,4,5-trimethoxybenzaldehyde synthesis method | |
GB201602855D0 (en) | Farrerol drug intermediates 2,6-dimethyl-acetanilide synthesis method | |
GB201720972D0 (en) | 2-Hydroxyquinoxaline drug intermediates synthesis method | |
GB201720968D0 (en) | Nicotinamide-N-oxide drug intermediates synthesis method | |
GB201715110D0 (en) | 2-nitro-4-aminobenzaldehyde drug intermediates synthesis method | |
GB201714448D0 (en) | Drug intermediates 3-methoxy-2-thiophenecarboxaldehyde synthesis method | |
GB201714445D0 (en) | Drug intermediates 1-methyl-2-quinolinone synthesis method | |
GB201714444D0 (en) | Drug intermediates N-methylpyridin-2-one synthesis method | |
GB201713555D0 (en) | Dipperidine drug intermediates disphenylketone synthesis method | |
GB201523232D0 (en) | Farrerol drug intermediates 2,6-dimethyl-acetanillide synthesis method | |
GB201713386D0 (en) | 4-pregnene-16a-methyl-17a-mellow-3, 20-diketone drug synthesis method | |
GB201705534D0 (en) | Drug intermediates parachlorobenzoic-acid synthesis method | |
GB201715108D0 (en) | P-aminobenzaldehyde drug intermediates synthesis method | |
GB201705845D0 (en) | Drugs intermediates 1,4-dibromo-2,3-butanediol synthesis method | |
GB201709973D0 (en) | Vitamin E acetate intermediates 2,3,5-trimethylbdnzoquinine synthesis method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |